New One-Pill flu treatment for kids shows promise in Late-Stage trial
NCT ID NCT06507813
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new flu medicine called ADC189 in 190 children aged 2 to 11 with influenza. The medicine is given as a single dose, either as a tablet or granules. The goal was to see if it is safe and works well in younger children, who currently have limited treatment options. The trial compared ADC189 to an existing drug and placebos.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ADC189 tablets/granules
- What this could lead to
- If successful, this could offer a convenient single-dose flu treatment for children as young as 2, filling a gap for younger kids.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. The drug may not prove safer or more effective than existing options, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Children's Hospital,Capital Medical University
Beijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital swab test tell COVID and flu apart at home?
- New swab test aims to spot COVID, flu, and RSV in minutes
- New device aims to detect flu, RSV, and COVID-19 in one quick test
- Scientists hunt for clues in COVID Patients' blood and secretions
- Experimental device trial: what you need to know
- New flu pill TRX-100 tested for safety and symptom relief